US Patent Issued to NOSTER on July 15 for "Composition for inhibiting growth of bacterium having menaquinone synthesis pathway through futalosine or futalosine derivative" (Japanese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,601, issued on July 15, was assigned to NOSTER INC. (Kyoto, Japan).

"Composition for inhibiting growth of bacterium having menaquinone synthesis pathway through futalosine or futalosine derivative" was invented by Hidenori Matsui (Tokyo) and Marina Kawaguchi (Kyoto, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a composition for inhibiting proliferation of a bacterium provided with a menaquinone synthesis route via futalosine or a futalosine derivative, which contains a fatty acid having 18 carbon atoms and a hydroxyl group at the 10-position as an active ingredient. Furthermore, the present invention provides a...